NCT03717844
- Conditions
- Abnormalities, Multiple, Amyloidosis, Blood Protein Disorders, +40 more
- Locations
-
- North Carolina Cancer Hospital Chapel Hill, North Carolina, United States
Clinical trial condition
Light Chain Deposition Disease
Explore clinical trials studying Light Chain Deposition Disease. Study availability and eligibility vary by location and protocol.
9 public trials
2 recruiting studies
Light Chain Deposition Disease trial results
NCT05283993
- Conditions
- Abnormalities, Multiple, Amyloidosis, Blood Protein Disorders, +44 more
- Locations
-
- Peking University First Hospital Beijing, China
NCT03820817
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Gammopathy Igg, +21 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
NCT00520767
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +11 more
- Locations
-
- Rocky Mountain Cancer Centers/Rocky Mountain Blood & Marrow Transplant Program Denver, Colorado, United States
- Boston University Cancer Research Center Boston, Massachusetts, United States
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
- Josephine Ford Cancer Center at Henry Ford Hospital Detroit, Michigan, United States
NCT01849783
- Conditions
- Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +24 more
- Locations
-
- University of Iowa Hospitals and Clinics Iowa City, Iowa, United States
NCT01078454
- Conditions
- Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +11 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- The Medical Center of Aurora Aurora, Colorado, United States
- Boulder Community Hospital Boulder, Colorado, United States
NCT01533194
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Completed
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy
NCT00890747
- Conditions
- AIDS-related Diffuse Large Cell Lymphoma, AIDS-related Diffuse Mixed Cell Lymphoma, AIDS-related Diffuse Small Cleaved Cell Lymphoma, +199 more
- Locations
-
- Jonsson Comprehensive Cancer Center Los Angeles, California, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Washington D.C., District of Columbia, United States
- Northwestern University Chicago, Illinois, United States
- AIDS - Associated Malignancies Clinical Trials Consortium Rockville, Maryland, United States
Active, Not Recruiting
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
NCT01169337
- Conditions
- Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
- Locations
-
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Women's Cancer Care Anchorage, Alaska, United States
- Anchorage Oncology Centre Anchorage, Alaska, United States
- Katmai Oncology Group Anchorage, Alaska, United States